Back
Arbutus Biopharma Corp. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
50
ABUS
Arbutus Biopharma Corp.
Last Price:
$4.43
Seasonality Move:
19.24%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABUS is experiencing selling pressure, which indicates risk of future bearish movement.
Arbutus Biopharma Corp. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.64 | Sell |
| 20-day SMA: | 4.47 | Sell |
| 50-day SMA: | 4.48 | Sell |
| 200-day SMA: | 3.76 | Buy |
| 8-day EMA: | 4.57 | Sell |
| 20-day EMA: | 4.53 | Sell |
| 50-day EMA: | 4.44 | Sell |
| 200-day EMA: | 3.95 | Buy |
Arbutus Biopharma Corp. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 47.25 | Sell |
| Chaikin Money Flow: | -3824011 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.28 - 4.64) | Sell |
| Bollinger Bands (100): | (3.77 - 4.67) | Buy |
Arbutus Biopharma Corp. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Arbutus Biopharma Corp. Stock
Is Arbutus Biopharma Corp. Stock a Buy?
-
Arbutus Biopharma Corp. share price is 4.43 while ABUS 8-day simple moving average is 4.64, which is a Sell signal.
-
The stock price of ABUS is 4.43 while Arbutus Biopharma Corp. 20-day SMA is 4.47, which makes it a Sell.
-
Arbutus Biopharma Corp. 50-day simple moving average is 4.48 while ABUS share price is 4.43, making it a Sell technically.
-
ABUS stock price is 4.43 and Arbutus Biopharma Corp. 200-day simple moving average is 3.76, creating a Buy signal.
ABUS Technical Analysis vs Fundamental Analysis
Sell
50
Arbutus Biopharma Corp. (ABUS)
is a Sell
Is Arbutus Biopharma Corp. a Buy or a Sell?
-
Arbutus Biopharma Corp. stock is rated a SellThe current Arbutus Biopharma Corp. [ABUS] share price is $4.43. The Score for ABUS is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
Arbutus Biopharma Corp. Stock Info
Market Cap:
852M
Price in USD:
4.43
Share Volume:
4.2M
Arbutus Biopharma Corp. 52-Week Range
52-Week High:
5.10
52-Week Low:
2.71
Sell
50
Arbutus Biopharma Corp. (ABUS)
is a Sell
Arbutus Biopharma Corp. Share Price Forecast
-
What is the Arbutus Biopharma Corp. stock price today?The Arbutus Biopharma Corp. stock price is 4.43 USD today.
-
Will ABUS stock go up or go down?Arbutus Biopharma Corp.> share price is forecast to RISE/FALL based on technical indicators
-
Is Arbutus Biopharma Corp. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Arbutus Biopharma Corp. is overvalued.
Is Arbutus Biopharma Corp. Stock a Buy?
-
Arbutus Biopharma Corp. share price is 4.43 while ABUS 8-day exponential moving average is 4.57, which is a Sell signal.
-
The stock price of ABUS is 4.43 while Arbutus Biopharma Corp. 20-day EMA is 4.53, which makes it a Sell.
-
Arbutus Biopharma Corp. 50-day exponential moving average is 4.44 while ABUS share price is 4.43, making it a Sell technically.
-
ABUS stock price is 4.43 and Arbutus Biopharma Corp. 200-day simple moving average is 3.95, creating a Buy signal.
Fundamental Analysis of Arbutus Biopharma Corp.
Is Arbutus Biopharma Corp. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.20 per share, and an increase next year of $0.02 per share.
Technical Analysis of Arbutus Biopharma Corp.
Should I short Arbutus Biopharma Corp. stock?
-
ABUS Moving Average Covergence Divergence (MACD) indicator is 0.04, suggesting Arbutus Biopharma Corp. is a Buy
-
Arbutus Biopharma Corp. Relative Strength Index (RSI) is 47.25, which suggest Arbutus Biopharma Corp. is oversold
-
The Bollinger Bands (25) for Arbutus Biopharma Corp. is (4.28 - 4.64), which suggest Arbutus Biopharma Corp. is a Buy
-
The Bollinger Bands (100) for Arbutus Biopharma Corp. is (3.77 - 4.67), which suggest Arbutus Biopharma Corp. is a Buy
* Arbutus Biopharma Corp. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.